These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9280053)

  • 1. In vitro crystallisation systems for the study of urinary stone formation.
    Achilles W
    World J Urol; 1997; 15(4):244-51. PubMed ID: 9280053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.
    Kavanagh JP
    Scanning Microsc; 1992 Sep; 6(3):685-704; discussion 704-5. PubMed ID: 1439665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for measuring crystallization in urolithiasis research: why, how and when?
    Hess B; Ryall RL; Kavanagh JP; Khan SR; Kok DJ; Rodgers AL; Tiselius HG
    Eur Urol; 2001 Aug; 40(2):220-30. PubMed ID: 11528202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis.
    Kok DJ; Papapoulos SE
    Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct.
    Tiselius HG; Hallin A; Lindbäck B
    Urol Res; 2001 Apr; 29(2):75-82. PubMed ID: 11396732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of stone formation.
    Balaji KC; Menon M
    Urol Clin North Am; 1997 Feb; 24(1):1-11. PubMed ID: 9048848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of agglomeration in the early stages of papillar stone formation.
    Söhnel O; Grases F; Garcia-Ferragut L
    Scanning Microsc; 1994; 8(3):513-21; discussion 521-2. PubMed ID: 7747153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.
    Labeeuw M; Gerbaulet C; Pozet N; Zech P; Traeger J
    Urol Res; 1981; 9(4):163-8. PubMed ID: 7269003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A contribution to the formation mechanism of calcium oxalate urinary calculi. IV. Experimental investigations of the intrarenal crystallisation of calcium oxalate in rabbit.
    Hienzsch E; Hesse A; Bothor C; Berg W; Roth J
    Urol Res; 1979 Sep; 7(3):223-6. PubMed ID: 505683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi.
    Frochot V; Daudon M
    Int J Surg; 2016 Dec; 36(Pt D):624-632. PubMed ID: 27847293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of urease-induced crystallisation in undiluted human urine using the Coulter counter technique.
    Wang YH; Grenabo L; Hedelin H; Holmäng S; Pettersson S
    Urol Res; 1991; 19(3):171-5. PubMed ID: 1887525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro formation of "urinary stones": generation of spherulites of calcium phosphate in gel and overgrowth with calcium oxalate using a new flow model of crystallization.
    Achilles W; Jöckel U; Schaper A; Burk M; Riedmiller H
    Scanning Microsc; 1995 Jun; 9(2):577-85; discussion 585-6. PubMed ID: 8714750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Lancet; 1986 May; 1(8489):1056-8. PubMed ID: 2871335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of stone formation.
    Mandel N
    Semin Nephrol; 1996 Sep; 16(5):364-74. PubMed ID: 8890393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of agglomeration in calcium oxalate monohydrate urolith development.
    Grases F; Millan A; Söhnel O
    Nephron; 1992; 61(2):145-50. PubMed ID: 1630537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible role of Tamm-Horsfall glycoprotein in calcium oxalate crystallisation.
    Yoshioka T; Koide T; Utsunomiya M; Itatani H; Oka T; Sonoda T
    Br J Urol; 1989 Nov; 64(5):463-7. PubMed ID: 2611614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
    Achilles W; Freitag R; Kiss B; Riedmiller H
    J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of lemon and orange juices on calcium oxalate crystallization.
    Kulaksizoğlu S; Sofikerim M; Cevik C
    Int Urol Nephrol; 2008; 40(3):589-94. PubMed ID: 17721827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.